• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

EDDA Technology Raises $150M in Funding Round Led By Softbank

Share:

April 13, 2021

Surgical robots developer EDDA Technology has closed a $150 million funding round; proceeds will enable it to capture untapped markets of intelligent surgical robots.

Masayoshi Son’s Softbank Vision Fund 2 led this round, along with global healthcare investment firm OrbiMed and Hong Kong-based 3W Fund. The company is also supported by Morningside Ventures, Matrix Partners China, SBCVC, BOCGI, Trust Bridge, and Draper Dragon.

WHAT IT DOES

EDDA Technology, a consortium of health tech firms based in the US and China, integrates artificial intelligence and robotics with precision surgery. Its IQQA platform supports pre-surgical planning and simulation, intra-operative navigation, and post-operative evaluation.

The company is also behind the IQQA Guide, a surgical navigation medical device for soft tissue organs, which is certified by both the US FDA and China’s NMPA.

WHAT IT’S FOR

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

In a statement last Wednesday, EDDA Technology CEO and President Dr. Jianzhong Qian said the proceeds from the funding round will be used to capture the untapped market for AI-powered surgical robots, such as hospitals in second and third-tier cities in China. They also plan to utilize the company’s technologies to facilitate the diagnosis and treatment of major diseases like cancer.

EDDA Technology’s IQQA products and services are now being used in hundreds of hospitals, including the Mayo Clinic in the US, and Peking Union Medical College Hospital; West China Hospital; and Shanghai Ruijin Hospital in China.

MARKET SNAPSHOT

The value of the surgical robotics market was estimated to expand to $12.6 billion by 2025 from $5.1 billion in 2017.

It was previously forecasted that healthcare providers’ spending on robotics in the Asia-Pacific region will top $7 billion by 2022. Meanwhile, the number of global digital health fundings last Q1 2021 reached 99, with a total value of $7.1 billion.

ON THE RECORD

“Modern surgery has entered a new precision era. EDDA Technology’s solution integrates intelligent medical imaging analytics with robots for precision surgery, and overcomes the problems of lack of intelligent planning and limited image guidance in traditional robot-assisted surgeries,” Qian said.

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • eSolutions Acquires Medidal, Solidifying Position in Hospital Revenue RecoveryeSolutions Acquires Medidal, Solidifying Position in Hospital Revenue Recovery
  • Laerdal Medical Chooses Ivalua to Drive Efficiency and Compliance Across Its Global OrganizationLaerdal Medical Chooses Ivalua to Drive Efficiency and Compliance Across Its Global Organization
  • BioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand PortfolioBioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand Portfolio
  • Pyxis Oncology to Acquire ApexigenPyxis Oncology to Acquire Apexigen
  • Golub Capital Provides One-Loan Debt Facility to Support the Acquisition of CRH Healthcare by Freeman Spogli & Co.Golub Capital Provides One-Loan Debt Facility to Support the Acquisition of CRH Healthcare by Freeman Spogli & Co.
  • Charles River Laboratories Completes the Acquisition of HemaCare CorporationCharles River Laboratories Completes the Acquisition of HemaCare Corporation
  • Ensemble Boosts Beebe’s Revenue Cycle: Healthcare PartnershipEnsemble Boosts Beebe’s Revenue Cycle: Healthcare Partnership
  • 3 AI Trends for 2020: Moving Beyond Dazzle to High-Impact Collaboration3 AI Trends for 2020: Moving Beyond Dazzle to High-Impact Collaboration

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications